Rittner H L, Stein C
Klinik für Anästhesiologie und Operative Intensivmedizin, Charité -- Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany.
Eur J Pain. 2005 Apr;9(2):109-12. doi: 10.1016/j.ejpain.2004.05.009.
Tissue destruction is accompanied by an inflammatory reaction. The inflammatory reaction leads to activation of nociceptors and the sensation of pain. Several mediators are responsible for pain and hyperalgesia in inflammation including cytokines, chemokines, nerve growth factor as well as bradykinin, prostaglandins and ATP. Simulatenously however, analgesic mediators are secreted: opioid peptides, somatostatin, endocannabinoids and certain cytokines. Opioid peptides secreted from immune cells are so far the best studied peptides in peripheral inflammatory pain control. This system is hampered for example by anti-adhesion molecule treatment. Novel immunosuppressive drugs for treatment of autoimmune disease targetting cytokines, chemokines or adhesion molecules should therefore be evaluated for potential harmful effects on pain.
组织破坏伴随着炎症反应。炎症反应会导致伤害感受器激活并产生疼痛感觉。多种介质会引发炎症中的疼痛和痛觉过敏,包括细胞因子、趋化因子、神经生长因子以及缓激肽、前列腺素和三磷酸腺苷。然而,与此同时也会分泌镇痛介质:阿片肽、生长抑素、内源性大麻素和某些细胞因子。免疫细胞分泌的阿片肽是目前在外周炎症性疼痛控制中研究得最为充分的肽类。例如,抗黏附分子治疗会阻碍这个系统。因此,对于治疗自身免疫性疾病的新型免疫抑制药物,若其作用靶点为细胞因子、趋化因子或黏附分子,应评估其对疼痛可能产生的有害影响。